As personalized medicine becomes more and more integral to - TopicsExpress



          

As personalized medicine becomes more and more integral to healthcare, neuroendocrine tumor patients may have a unique opportunity. Columbia University Medical researchers in New York City are developing a new approach to clinical trials, designing and testing therapies on one patient at a time. Dr. Andrea Califano and his colleagues are currently testing this individualized approach to cancer in a handful of patients with gastric and neuroendocrine tumors. Based on what they have learned from these "N-of-1" (N being the number of patients in a study) studies, they are designing a new clinical trial protocol to study an estimated 30–40 patients with pancreatic, gastric, neuroendocrine, and other tumors that have not responded to conventional therapy. Read more: medicalxpress/news/2013-07-clinical-trials-cancer-patient.html
Posted on: Tue, 16 Jul 2013 19:48:34 +0000

Trending Topics



Recently Viewed Topics




© 2015